SUNESIS PHARMACEUTICALS INC (SNSS) has 67 open-market insider trades by 30 insiders since 2005. The most active filer is Daniel N. Swisher Jr., President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Dayton Misfeldt | Dir | — | 6 | $18.5M | 2017-10-27 |
| Krishna Kittu Kolluri | 10% | — | 3 | $13.5M | 2014-08-29 |
| Ryan D. Drant | 10% | — | 3 | $13.5M | 2014-08-29 |
| Forest Baskett | 10% | — | 3 | $13.5M | 2014-08-29 |
| Patrick J. Kerins | 10% | — | 3 | $13.5M | 2014-08-29 |
| Scott D. Sandell | 10% | — | 3 | $13.5M | 2014-08-29 |
| Jonathan S. Leff | Dir | — | 2 | $8.0M | 2007-05-30 |
| NEA Partners 12, Limited Partnership via M. James Barrett | 10% | — | 2 | $6.8M | 2014-08-29 |
| M. James Barrett | 10% | — | 2 | $6.8M | 2014-08-29 |
| Peter J. Barris | 10% | — | 2 | $6.8M | 2014-08-29 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Tina Gullotta | VP & Finance | Buy | $2K | 2020-05-29 |
| Aisling Capital Partners IV, LP | 10% Owner | Buy | $1.5M | 2019-07-15 |
| William P. Quinn | — | Buy | $6K | 2019-05-31 |
| William P. Quinn | CFO & Sr.V.P. Finance +1 | Buy | $19K | 2018-12-10 |
| MPM Oncology Impact Management LP | 10% Owner | Buy | $226K | 2017-11-02 |
| Dayton Misfeldt | Director | Buy | $800K |
Companies that share insiders with SNSS, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2017-10-27 |
| Geoffrey M. Parker | Director | Buy | $14K | 2016-12-08 |
| Geoffrey M. Parker | Director | Buy | $4K | 2016-05-26 |
| Geoffrey M. Parker | Director | Buy | $25K | 2016-05-24 |
| Dayton Misfeldt | Director | Buy | $1.5M | 2015-12-21 |
| Daniel N. Swisher Jr. | President | Buy | $25K | 2015-08-24 |
| Steven B. Ketchum | Director | Sell | $22K | 2015-07-24 |
| Daniel N. Swisher Jr. | President | Sell | $44K | 2015-07-24 |
| Daniel N. Swisher Jr. | President | Buy | $26K | 2015-07-24 |
| Dayton Misfeldt | Director | Sell | $2.2M | 2015-07-24 |